Case Database
Filter every documented case by date, drug, state, setting, role, prosecution status, and penalty. Search accepts brand or generic drug names, facility names, and cities.
Showing 2 of 931 cases.
| Case / When | Where | Setting | Drug | Method | Role | Prosecution status | Penalty | Source |
|---|---|---|---|---|---|---|---|---|
|
Hospital pharmacy manager diverted hydromorphone, methadone and morphine from a CII safe using unused transaction types
2024-07
|
Indiana Muncie, IN |
Indiana University Health Ball Memorial Hospital, Inc. | hydromorphone, methadone, morphine sulfate | Between approximately November 2020 and July 2024, a pharmacist serving as the hospital's pharmacy manager used normally-unused transaction types in the automated inventory management system to remove controlled substances from the CII safe and take personal possession of them, using his duty of stocking controlled substances at affiliated outpatient pain and orthopedic centers as cover. The hospital's controlled-substance tracking policies did not include regular auditing or comparison of patient utilization at those centers, CII Safe Review Sale reports, or All CII Safe Events reports, which allowed the discrepancies to go undetected. | not stated | The hospital's pharmacy license and controlled substances registration were placed on indefinite probation for not less than three years, with quarterly outside audits for the first two years, two unannounced compliance inspections, required diversion-prevention training for pharmacy leadership, and a $44,000 fine; the hospital reported the loss to the DEA and Board in July 2024 and filed an amended DEA Form 106 in November 2024, and in August 2025 the county prosecutor's office filed charges against the pharmacist. | none documented | source |
|
Psychiatrist found to have unlawfully possessed controlled substances taken back from patients and kept no required records
2013-09
|
New Mexico Albuquerque, NM |
private psychiatric practice | controlled substances including fentanyl patches, oxycodone, OxyContin, methadone, Suboxone, hydrocodone, benzodiazepines, and Lyrica samples | Took back and retained already-dispensed controlled substances directly from patients outside the CSA's closed distribution system, and failed to maintain any inventory or records of the controlled substances he received or the drug samples kept in his office; a separate allegation that he redistributed these drugs to other patients was investigated but found unproven. | not stated | DEA registration renewal granted subject to a six-month suspension and restriction to non-narcotic controlled substances only; DATA-Waiver authority to prescribe Suboxone/Subutex revoked. | none documented | source |
Every filtered view has its own URL, so it can be linked or bookmarked. The same filters work on the JSON feed: /api/cases.json.
What each column does and doesn't cover
Every case states When (date) and Where (state) — 931 of 931. Beyond that, a blank cell means the source record does not state that fact, not that it did not happen:
- Setting: stated in 850 of 931 cases (91%)
- Drug: stated in 858 of 931 cases (92%)
- Method: stated in 675 of 931 cases (73%)
- Prosecution status: stated in 675 of 931 cases (73%); a documented penalty (fine, settlement, or restitution) exists for 107 of 931 cases (11%)
- Role: stated in only 255 of 931 cases (27%) — filtering or sorting by role silently hides the rest of the registry, which may still describe the same role in prose without a structured field
Disclaimer
Case summaries are based on public records (DOJ press releases, court documents, news reports). Charges are allegations unless a conviction is noted. Analysis is educational, not legal advice.
Last reviewed: September 2026 · Content is educational, not legal advice.